Natco Pharma informed exchanges that it received an NPPA demand notice of around ₹4.92 crore under DPCO, 2013, related to alleged overcharging of two drugs between April 2023 and November 2023. Ace investor Akash Bhanshali held 1.01% stake in Natco Pharma as of March 2026, while promoters owned 49.41% stake.